bazedoxifene has been researched along with Spinal Cord Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, H; Han, I; Joshi, HP; Kim, Y; Kwon, SY; Roh, EJ; Shin, HE; Sohn, S | 1 |
| Baokun, Z; Erzhu, Y; Jianguang, X; Qiang, S; Xiaofeng, L; Xin, W; Zhiheng, C | 1 |
2 other study(ies) available for bazedoxifene and Spinal Cord Injuries
| Article | Year |
|---|---|
Bazedoxifene, a Selective Estrogen Receptor Modulator, Promotes Functional Recovery in a Spinal Cord Injury Rat Model.
Topics: Animals; Apoptosis; Cell Line; Cell Survival; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Indoles; Interleukin-6; Mice; Neovascularization, Physiologic; Neurons; Nitric Oxide; Phosphorylation; Rats; Rats, Sprague-Dawley; Recovery of Function; Selective Estrogen Receptor Modulators; Spinal Cord Injuries | 2021 |
Biodegradable bilayer hydrogel membranes loaded with bazedoxifene attenuate blood-spinal cord barrier disruption via the NF-κB pathway after acute spinal cord injury.
Topics: Animals; Blood-Brain Barrier; Brain Injuries, Traumatic; Hemorrhage; Hydrogels; Inflammation; NF-kappa B; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Cord Injuries; Tight Junction Proteins | 2023 |